论文部分内容阅读
目的:分析替罗非班治疗老年急性非ST段抬高心肌梗死合并糖尿病效果。方法:选取64例行PCI治疗(急诊介入治疗)老年急性非ST段抬高心肌梗死合并糖尿病,随机分为对照组(32)与治疗组(32),对照组采用常规药物治疗,治疗组采用替罗非班治疗,对比两组疗效。结果:两组BNP、LVESD、LVEDD、LVEF、TIMI血流计帧有明显差异(P<0.05)。治疗组心绞痛发作低于对照组(P<0.05)。结论:对老年急性非ST段抬高心肌梗死合并糖尿病患者采用替罗非班治疗,安全有效,改善患者预后。
Objective: To analyze the effect of tirofiban in the treatment of elderly patients with acute non-ST-elevation myocardial infarction complicated with diabetes mellitus. Methods: Totally 64 elderly patients with acute non-ST-elevation myocardial infarction complicated with diabetes mellitus undergoing PCI (emergency intervention) were randomly divided into control group (32) and treatment group (32), and the control group was treated with conventional drugs. The treatment group Tirofiban treatment, the two groups compared efficacy. Results: There were significant differences in BNP, LVESD, LVEDD, LVEF and TIMI flowmetry frames between the two groups (P <0.05). The incidence of angina pectoris in the treatment group was lower than that in the control group (P <0.05). Conclusion: The use of tirofiban in elderly patients with acute non-ST-elevation myocardial infarction complicated with diabetes mellitus is safe and effective and the prognosis is improved.